Biomarkers in systemic lupus erythematosus - II. Markers of disease activity

被引：118
作者：
Illei, GG [1 ]
Tackey, E [1 ]
Lapteva, L [1 ]
Lipsky, PE [1 ]
机构：
[1] NIAMSD, NIH, DHHS, Bethesda, MD 20892 USA
来源：
ARTHRITIS AND RHEUMATISM | 2004年 / 50卷 / 07期
关键词：
D O I：
10.1002/art.20345
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：2048 / 2065
页数：18
相关论文
共 179 条
[31]   ASSESSMENT OF DISEASE-ACTIVITY AND IMPENDING FLARE IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS - COMPARISON OF THE USE OF COMPLEMENT SPLIT PRODUCTS AND CONVENTIONAL MEASUREMENTS OF COMPLEMENT [J].
BUYON, JP ;
TAMERIUS, J ;
BELMONT, HM ;
ABRAMSON, SB .
ARTHRITIS AND RHEUMATISM, 1992, 35 (09) :1028-1037
[32]  
CASALI P, 1977, CLIN EXP IMMUNOL, V29, P342
[33]   Interleukin-1 and interleukin-1 receptor antagonist in systemic lupus erythematosus [J].
Chang, DM .
IMMUNOLOGICAL INVESTIGATIONS, 1997, 26 (5-7) :649-659
[34]  
Cheema GS, 2001, ARTHRITIS RHEUM-US, V44, P1313, DOI 10.1002/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO
[35]  
2-S
[36]  
Chiu YY, 1998, J INVEST ALLERG CLIN, V8, P239
[37]   Lymphocyte apoptosis in systemic lupus erythematosus: relationships with Fas expression, serum soluble Fas and disease activity [J].
Courtney, PA ;
Crockard, AD ;
Williamson, K ;
McConnell, J ;
Kennedy, RJ ;
Bell, AL .
LUPUS, 1999, 8 (07) :508-513
[38]  
CUADRADO MJ, 1993, LUPUS, V2, P257
[39]   SERUM LEVELS OF SOLUBLE INTERLEUKIN-2 RECEPTOR IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS AND SYSTEMIC IDIOPATHIC VASCULITIS [J].
DANIELI, MG ;
PAOLETTI, P ;
RECCHIONI, A ;
GABRIELLI, A ;
DANIELI, G .
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1993, 22 (05) :215-219
[40]   Serum IL-6, TNFα, p55 srTNFα, p75 srTNFα, srIL-2α levels and disease acitivity in systemic lupus erythematosus [J].
Davas, EM ;
Tsirogianni, A ;
Kappou, I ;
Karamitsos, D ;
Economidou, I ;
Dantis, PC .
CLINICAL RHEUMATOLOGY, 1999, 18 (01) :17-22
12345678910